Science
Two biotech companies, Germany’s BioNTech and the U.S.’s Moderna, decided in January 2020 to wager their futures on developing a messenger RNA shot to fight Covid-19. What ensued was a head-spinning race to bring a vaccine to market quicker than ever before.
See omnystudio.com/listener for privacy information.
More Episodes
The Swedish Strategy
2020-08-31
2020-08-31
South Africa's Multiple Epidemics
2020-08-28
2020-08-28
The FDA Under Pressure
2020-08-26
2020-08-26
What Do We Really Know About Plasma?
2020-08-24
2020-08-24
The Future of Packed Tourist Towns
2020-08-21
2020-08-21
The Pandemic During Flu Season
2020-08-19
2020-08-19
The Shadow Over College Athletics
2020-08-17
2020-08-17
Our Vaccine Expectations Are Unrealistic
2020-08-14
2020-08-14
The Race Gap in Clinical Trials
2020-08-12
2020-08-12
The Cost of Keeping Schools Safe
2020-08-10
2020-08-10
A Generation of Health Damage
2020-08-07
2020-08-07
Will Kids Spread COVID to Teachers?
2020-08-05
2020-08-05
The Promise of a New Treatment
2020-08-03
2020-08-03
What We Know About Immunity
2020-07-31
2020-07-31
The Data Disaster in the U.S.
2020-07-29
2020-07-29
Why a Vaccine Won't Create Instant Immunity
2020-07-27
2020-07-27
The Campaign to Lure You Back to the Doctor
2020-07-22
2020-07-22
The First Vaccine May Not Be the Best
2020-07-17
2020-07-17
Get this podcast on your
phone, FREE
